Education
About Us
Working with TipRanks
Follow Us
Relief Therapeutics Holding Ag (CH:RLF)
:RLF
RESEARCH TOOLSreports
RLF Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF1.06 - CHF7.60
Previous CloseN/A
Volume10.22K
Average Volume (3M)20.72K
Market Cap
CHF31.00M
Enterprise ValueCHF39.86M
Total Cash (Recent Filing)CHF15.08M
Total Debt (Recent Filing)CHF2.14M
Price to Earnings (P/E)―
Beta-0.68
Next Earnings
Aug 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.00
Shares Outstanding14,076,317
10 Day Avg. Volume40,710
30 Day Avg. Volume20,716
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF2.50Price Target Upside-0.78% Downside
Rating ConsensusHold
Number of Analyst Covering0
RELIEF THERAPEUTICS Holding News
RLF FAQ
What was Relief Therapeutics Holding Ag’s price range in the past 12 months?
Relief Therapeutics Holding Ag lowest stock price was CHF1.05 and its highest was CHF7.60 in the past 12 months.
What is Relief Therapeutics Holding Ag’s market cap?
Relief Therapeutics Holding Ag’s market cap is CHF31.00M.
When is Relief Therapeutics Holding Ag’s upcoming earnings report date?
Relief Therapeutics Holding Ag’s upcoming earnings report date is Aug 29, 2025 which is in 20 days.
How were Relief Therapeutics Holding Ag’s earnings last quarter?
Currently, no data Available
Is Relief Therapeutics Holding Ag overvalued?
According to Wall Street analysts Relief Therapeutics Holding Ag’s price is currently Overvalued.
Does Relief Therapeutics Holding Ag pay dividends?
Relief Therapeutics Holding Ag does not currently pay dividends.
What is Relief Therapeutics Holding Ag’s EPS estimate?
Relief Therapeutics Holding Ag’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Relief Therapeutics Holding Ag have?
Relief Therapeutics Holding Ag has 14,076,317 shares outstanding.
What happened to Relief Therapeutics Holding Ag’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Relief Therapeutics Holding Ag?
Currently, no hedge funds are holding shares in CH:RLF
Company Description
Relief Therapeutics Holding Ag
RELIEF THERAPEUTICS Holding AG is a Swiss-based biopharmaceutical company focused on developing and commercializing novel, patent-protected products in the areas of rare metabolic and genetic disorders, as well as respiratory diseases. The company is committed to providing therapeutic relief and improving the quality of life for patients with serious medical conditions. RELIEF THERAPEUTICS operates in the healthcare and biotechnology sectors, leveraging its expertise in drug development and strategic partnerships to bring innovative treatments to market.
RELIEF THERAPEUTICS Holding (RLF) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Molecular Partners AG
―
Newron Pharmaceuticals SpA
―
Santhera Pharmaceuticals Holding
―
Evolva Holding
―
Ownership Overview
― Insiders
0.01%
Mutual Funds
<0.01% Other Institutional Investors
99.82% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---